Product NDC: | 43386-660 |
Proprietary Name: | Trimethobenzamide Hydrochloride |
Non Proprietary Name: | Trimethobenzamide Hydrochloride |
Active Ingredient(s): | 300 mg/1 & nbsp; Trimethobenzamide Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 43386-660 |
Labeler Name: | GAVIS Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076546 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110117 |
Package NDC: | 43386-660-24 |
Package Description: | 100 CAPSULE in 1 BOTTLE (43386-660-24) |
NDC Code | 43386-660-24 |
Proprietary Name | Trimethobenzamide Hydrochloride |
Package Description | 100 CAPSULE in 1 BOTTLE (43386-660-24) |
Product NDC | 43386-660 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Trimethobenzamide Hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20110117 |
Marketing Category Name | ANDA |
Labeler Name | GAVIS Pharmaceuticals, LLC |
Substance Name | TRIMETHOBENZAMIDE HYDROCHLORIDE |
Strength Number | 300 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Antiemetic [EPC],Emesis Suppression [PE] |